The use of artificial intelligence (AI) in the biopharma industry has the potential to revolutionise drug discovery and development, as well as improve patient care. By analysing large amounts of data, AI algorithms can identify patterns and relationships that may not be apparent to humans, leading to new insights and therapies.
Comments